Enhanced Luminescence-based Method for Precise Delivery of Ion Beam Therapy

Publication ID: 24-11857806_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Luminescence-based Method for Precise Delivery of Ion Beam Therapy,” Published Technical Disclosure No. 24-11857806_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857806_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,806.

Summary of the Inventive Concept

An improved method for precise delivery of ion beam therapy, utilizing advanced luminescence-based markers and real-time tracking to minimize radiation damage and enhance treatment accuracy.

Background and Problem Solved

Conventional radiation therapy methods often result in unwanted radiation exposure to surrounding tissue. The original patent, 'Luminescence-based method for precise delivery of ion beam therapy', addressed this issue by using an EUD4TEA-inclusive marker to track ion beam delivery. However, the original method had limitations in terms of radiation damage to surrounding tissue and accuracy of ion beam delivery. The new inventive concept builds upon the original patent by introducing optimized markers, real-time tracking, and dynamic ion beam intensity adjustment to further minimize radiation damage and enhance treatment accuracy.

Detailed Description of the Inventive Concept

The new inventive concept comprises a system for precise delivery of ion beam therapy, featuring a luminescence-based marker optimized for reduced radiation damage to surrounding tissue. The marker is designed to track ion beam delivery in real-time, allowing for dynamic adjustment of the ion beam trajectory and intensity. The system includes a novel triboluminescent material that emits light in response to ion beam impingement, which is detected by a sensor. This enables real-time monitoring of ion beam therapy and ensures accurate treatment. The inventive concept also encompasses methods for enhancing the accuracy of ion beam therapy, reducing radiation exposure, and providing real-time monitoring of ion beam therapy.

Novelty and Inventive Step

The new inventive concept introduces several novel and non-obvious features compared to the original patent, including optimized luminescence-based markers, real-time tracking, and dynamic ion beam intensity adjustment. These advancements enable more precise and efficient ion beam therapy, while minimizing radiation damage to surrounding tissue.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different luminescent materials, varying marker designs, or alternative detection methods. Additionally, the inventive concept could be adapted for use in other forms of radiation therapy, such as gamma knife therapy or proton therapy.

Potential Commercial Applications and Market

The enhanced luminescence-based method for precise delivery of ion beam therapy has significant commercial potential in the radiation oncology market, with potential applications in cancer treatment centers, hospitals, and research institutions. The inventive concept's ability to minimize radiation damage and enhance treatment accuracy makes it an attractive solution for healthcare providers seeking to improve patient outcomes.

Field of Art

Radiation Oncology and Medical Physics, focusing on targeted ion beam therapy and luminescence-based tracking technologies for cancer treatment

Person of Ordinary Skill (PHOSITA) Profile

A medical physicist or radiation oncology engineer with expertise in radiation delivery systems, advanced imaging techniques, and therapeutic marker technologies, holding advanced degrees in medical physics or biomedical engineering

Obviousness Rationale

A PHOSITA would recognize that the PTD represents a predictable extension of the source patent's core luminescence-based ion beam therapy methodology. The disclosed variations introduce incremental improvements in marker design, real-time tracking, and beam trajectory adjustment that would be considered routine optimization within the field. The technical solutions proposed represent logical refinements that would be apparent to a skilled practitioner seeking to enhance precision in radiation therapy delivery.

Obvious Combinations & Variations

Source Patent Element
EUD4TEA-inclusive marker for tracking ion beam delivery
PTD Variation
Novel triboluminescent marker with enhanced real-time tracking capabilities
Obviousness Reasoning
Modifying marker composition to improve luminescence response is a predictable design variation that would be obvious to a PHOSITA seeking improved radiation therapy precision
Source Patent Element
Ion beam directed toward skin marker for cancer treatment
PTD Variation
Dynamic ion beam trajectory and intensity adjustment based on marker luminescence
Obviousness Reasoning
Implementing real-time feedback mechanisms for beam control represents a known technique for improving radiation therapy accuracy and minimizing surrounding tissue damage
Source Patent Element
Basic luminescence-based tracking method
PTD Variation
Computer algorithm for analyzing marker luminescence response to ensure treatment accuracy
Obviousness Reasoning
Integrating computational analysis with existing luminescence tracking is a straightforward technological improvement using standard signal processing techniques
Source Patent Element
Ion beam therapy targeting specific cancer locations
PTD Variation
Optimized marker design for reduced radiation damage to surrounding tissue
Obviousness Reasoning
Developing markers that minimize collateral radiation exposure is an expected design optimization within radiation therapy technology
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857806 and the disclosed technical variations, a person having ordinary skill in the art would find the proposed ion beam therapy tracking and delivery improvements to be obvious variations that do not represent a non-obvious invention. The incremental advancements in luminescence-based marker technology and real-time beam control represent predictable extensions of existing radiation therapy methodologies.

Original Patent Information

Patent NumberUS 11,857,806
TitleLuminescence-based method for precise delivery of ion beam therapy
Assignee(s)United States of America as represented by the Secretary of the Navy